Cargando…
Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer
Breast cancer is one of the most common cancers in women. Triple-negative breast cancer (TNBC) has a significantly worse prognosis due to the lack of endocrine receptors including estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2). In this study, w...
Autores principales: | Yang, Xinyi, Weng, Desheng, Pan, Qiuzhong, Xiang, Tong, Yang, Chaopin, Wu, Zhengrong, Li, Minxing, Xie, Songzuo, Tang, Yan, Xia, Jianchuan, Zhao, Jingjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686374/ https://www.ncbi.nlm.nih.gov/pubmed/36439119 http://dx.doi.org/10.3389/fimmu.2022.974487 |
Ejemplares similares
-
Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection
por: Pan, Qiu-Zhong, et al.
Publicado: (2020) -
Cytokine-induced killer cell/dendritic cell combined with cytokine-induced killer cell immunotherapy for treating advanced gastrointestinal cancer
por: Du, Hansong, et al.
Publicado: (2020) -
Efficacy of Enhanced Cytokine-Induced Killer Cells as an Adjuvant Immunotherapy for Renal Cell Carcinoma: Preclinical and Clinical Studies
por: Yang, Yang, et al.
Publicado: (2021) -
A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma
por: Pan, Qiu-Zhong, et al.
Publicado: (2015) -
Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis
por: Yuan, Xin, et al.
Publicado: (2021)